Sodium benzoate enhances schizophrenia treatment
A randomised, double-blind, placebo-controlled trial has found that sodium benzoate improves symptoms in clozapine-resistant schizophrenia...
List view / Grid view
A randomised, double-blind, placebo-controlled trial has found that sodium benzoate improves symptoms in clozapine-resistant schizophrenia...
Researchers have found evidence in human ovarian tissue that exposure to ibuprofen during the first three months of foetal development results in a dramatic loss of the germ cells...
Researchers have successfully applied a novel combination therapy to restore skin colour in patients with vitiligo...
Injecting minute amounts of two immune-stimulating agents directly into solid tumours in mice can eliminate all traces of cancer...
A new study reveals the efficacy and safety of using intravenous bevacizumab to treat patients with severe hereditary haemorrhagic telangiectasia (HHT). Successful results suggest it should be used as a first-line therapy.
A team of scientist have developed a way to wirelessly deliver light into deep regions of the body to activate light-sensitive drugs for photodynamic therapy...
Physicians have reported the first paediatric use of pyridostigmine to reverse complications from botulinum toxin therapy...
The EMA has recommended granting a marketing authorisation in the EU for Lamzede a long-term enzyme replacement therapy for alpha-mannosidosis...
Miniaturised system could be used to treat neurological disorders that affect specific brain regions...
Treatment with a pharmaceutical formulation of cannabidiol alongside other anti-epilepsy treatments helped to reduce the number of drop seizures in people with Lennox-Gastaut syndrome...
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity...
Addition of hydroxyurea to current chemotherapy significantly improved survival in animal models of glioblastoma...
An international research team has conducted successful phase II clinical tests of a new anti-malaria medication...
Researchers have shown that the synthetically manufactured vaccine BM32 relieves the symptoms of rhinitis...
The FDA has approved a supplemental New Drug Application for Gilotrif for the first-line treatment of patients with metastatic non-small cell lung cancer...